Aardvark Therapeutics SEC Filings
NASDAQ: AARDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.76+0.05 (+1.06%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Aardvark Therapeutics filing overview
This page lists 2 recent SEC filings by Aardvark Therapeutics (AARD), including 1 8-K, 1 4. The latest current report (8-K), used to disclose material events such as earnings releases and executive changes, was filed on Oct 8, 2026. Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
AARD SEC filings
| Filed | Form | Description | Document |
|---|---|---|---|
| Oct 8, 2026 | 8-K | Departure or Appointment of Directors or Officers; Compensatory Arrangements; Other Events | View on EDGAR |
| Oct 8, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |